Xiangyu Medical Co Ltd
SSE:688626
Relative Value
The Relative Value of one
Xiangyu Medical Co Ltd
stock under the Base Case scenario is
32.55
CNY.
Compared to the current market price of 66.28 CNY,
Xiangyu Medical Co Ltd
is
Overvalued by 51%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
Xiangyu Medical Co Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Xiangyu Medical Co Ltd
SSE:688626
|
10.6B CNY | 13.9 | 129.8 | 179.7 | 179.7 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
199.6B USD | 4.5 | 30.6 | 17.3 | 23.6 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
179.1B USD | 17.8 | 62.7 | 47.7 | 58.6 | |
| US |
|
Stryker Corp
NYSE:SYK
|
146.9B USD | 5.8 | 45.3 | 22.9 | 27.7 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
124.2B USD | 3.5 | 26.9 | 14.6 | 21.2 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
109.8B USD | 5.5 | 37.9 | 22.6 | 30.3 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
47.1B EUR | 2.1 | 22.6 | 12.4 | 17.5 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
52.7B USD | 12.3 | 49.8 | 35.6 | 39.2 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
51.6B USD | 2.3 | 29.3 | 11.2 | 18.9 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.7B USD | 8 | 45.1 | 25 | 27.4 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
38.3B USD | 1.9 | 18.4 | 13 | 15.7 |